James Mojirade 4
4 · AVANOS MEDICAL, INC. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
James Mojirade
SVP, General Counsel
Transactions
- Award
Common Stock
2024-03-06$19.14/sh+30,695$587,502→ 72,948 total - Tax Payment
Common Stock
2024-03-06$19.00/sh−1,951$37,069→ 70,997 total
Footnotes (2)
- [F1]Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027.
- [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6, 2025 and the remaining 1/3 will vest on March 6, 2026.